Our Research Publications
Updated August 2025
Pagination
- Previous page
- Page 24
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Balitsky A, Arnold D | 2022 | Transfusion | View Transfusion thresholds in myelodysplastic syndrome - Helping patients live better | Health care providers | Clinical research |
A cross-sectional study of haemolytic disease of the newborn in Uganda | Dhabangi A, Nankunda J, Okaba V, Nakubulwa S, Hume HA, Dzik WH, Heddle NM | 2022 | Vox Sang | View A cross-sectional study of haemolytic disease of the newborn in Uganda | Health care providers | Clinical research |
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Hillis C, Vicente C, Ball G | 2022 | Pharmacoeconomics | View The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada | Researchers | Clinical research |
The Missing Pieces to the Cold-Stored Platelet Puzzle | Zhao H, Devine DV | 2022 | Int J Mol Sci | View The Missing Pieces to the Cold-Stored Platelet Puzzle | Researchers | Basic research |
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Qi X, Hatami S, Bozso S, Buchko M, Forgie KA, Olafson C, Khan M, Himmat S, Wang X, Nobes DS, Acker JP, Nagendran J, Freed DH | 2022 | J Heart Lung Transplant | View The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion | Researchers | Basic research |
Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies | Gajic-Veljanoski O, Li C, Schaink AK, Guo J, Shehata N, Charames GS, de Vrijer B, Clarke G, Pechlivanoglou P, Okun N, Kandel R, Dooley J, Higgins C, Ng V, Sikich N | 2022 | Transfusion | View Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies | Researchers | Clinical research |
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Aubé E, Lewin A, O'Brien SF, Grégoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Seed CR, Camirand Lemyre F, the Surveillance RA, Policy Subgroup of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Blood operators | MSM research |
The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Asamoah-Boaheng M, Goldfarb DM, Karim ME, O’Brien SF, Wall N, Drews SJ, Barakauskas V, Jassem AN, Grunau B | 2022 | J Infect Dis | View The Relationship Between Anti-Spike SARS-CoV-2 Antibody Levels and Risk of Breakthrough COVID-19 Among Fully Vaccinated Adults | Researchers | Clinical research |
HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Lambert G, Cox J, Fourmigue A, Dvorakova M, Apelian H, Moodie EEM, Grace D, Skakoon-Sparling S, Moore DM, Lachowsky N, Jollimore J, Lal A, Parlette A, Hart TA | 2022 | Transfusion | View HIV incidence and related risks among gay, bisexual, and other men who have sex with men in Montreal, Toronto, and Vancouver: Informing blood donor selection criteria in Canada | Researchers | MSM research |
Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study | Trépanier P, Fournier D, Simard C, Fontaine MJ, Stroncek D, Takanashi M, McKenna D, Schwartz J, Tanhehco YC, Reems J-A, Torrents S, Kogler G, Liedtke S, Giroux M, Holovati JL, Louis I, Prasath A, Pineault N, Bazin R, The Biomedical Excellence for Safer Transfusion Collaborative | 2022 | Transfusion | View Multicenter evaluation of the IL-3-pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study | Researchers | Benchmarking and standard setting |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Drews S, Devine D, McManus J, Mendoza E, Manguiat K, Girardin R, Dupuis A, McDonough K, Lin J, Evans D, Pambrun C, Drebot M, Wood H | 2022 | Transfus Med Rev | View Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020) | Blood operators | New or improved product or process |
Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W | 2022 | Blood.ca website | View Plaquettes extraites de la couche leucoplaquettaire à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Boligan KF, Sandhu G, Branch DR | 2022 | Curr Protoc | View Methods to Evaluate the Potential Clinical Significance of Antibodies to Red Blood Cells | Researchers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Why We Swab: A library of stories in stem cell donation | Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB | 2022 | Transfusion | View Why We Swab: A library of stories in stem cell donation | Health care providers | Ethical, legal & social implications research |
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Lin Y-CJ, Evans DH, Robbins NF, Orjuela G, Hu Q, Samson R, Abe KT, Rathod B, Colwill K, Gingras A-C, Tuite A, Yi Q-L, O’Brien SF, Drews SJ | 2022 | Microbiol Spectr | View Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses | Health care providers | Benchmarking and standard setting |
Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | O’Brien SF, Drews SJ, Lewin A, Osiowy C, Drebot MA, Renaud C | 2022 | Relevé des maladies transmissibles au Canada | View Les fournisseurs de sang canadiens : un rôle croissant dans la surveillance de la santé publique? | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Surveillance report 2020 | O'Brien S | 2021 | Blood.ca website | View Surveillance report 2020 | Health care providers | Benchmarking and standard setting |
Répercussions de la COVID-19 sur le don de sang au Canada | Khandelwal A | 2021 | Blood.ca website | View Répercussions de la COVID-19 sur le don de sang au Canada | Health care providers | Benchmarking and standard setting |
Syndrome respiratoire aigu post-transfusionnel (TRALI) | Gupta A, Yan M | 2021 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Health care providers | Benchmarking and standard setting |
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Bourguignon A, Arnold DM, Warkentin TE, Smith JW, Pannu T, Shrum JM, Al Maqrashi ZAA, Shroff A, Lessard M-C, Blais N, Kelton JG, Nazy I | 2021 | N Engl J Med | View Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Clinical research |
ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Abe T | 2021 | Blood.ca website | View ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Health care providers | Clinical research |
A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies | Yao Z, Drecun L, Aboualizadeh F, Kim SJ, Li Z, Wood H, Valcourt EJ, Manguiat K, Plenderleith S, Yip L, Li X, Zhong Z, Yue FY, Closas T, Snider J, Tomic J, Drews SJ, Drebot MA, McGeer A, Ostrowski M, Mubareka S, Rini JM, Owen S, Stagljar I | 2021 | Nat Commun | View A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies | Researchers | New or improved product or process |
Releasates of riboflavin/UV-treated platelets: Microvesicles suppress cytokine-mediated endothelial cell migration/proliferation | Schubert P, Culibrk L, Culibrk B, Conway EM, Goodrich RP, Devine DV | 2021 | Transfusion | View Releasates of riboflavin/UV-treated platelets: Microvesicles suppress cytokine-mediated endothelial cell migration/proliferation | Researchers | Basic research |
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Writing Committee for the REMAP-CAP Investigators | 2021 | JAMA | View Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial | Health care providers | Clinical research |
Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time | Stonebraker JS, O'Mahony B, Noone D, Iorio A | 2021 | Haemophilia | View Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time | Researchers | Benchmarking and standard setting |
Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Prokopchuk-Gauk O, Petraszko T, Nahirniak S, Doncaster C, Levy I | 2021 | Transfusion | View Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID-19 pandemic | Regulators | Benchmarking and standard setting |
Concentré de recherche: Précision et efficacité accrues dans la gestion des réserves de sang | Li N | 2021 | Blood.ca website | View Concentré de recherche: Précision et efficacité accrues dans la gestion des réserves de sang | Health care providers | New or improved product or process |
Examining prescribing practices with respect to oral iron supplementation for post-partum anemia: a retrospective review | Iancu AM, Buckstein J, Melamed N, Lin Y | 2021 | J Matern Fetal Neonatal Med | View Examining prescribing practices with respect to oral iron supplementation for post-partum anemia: a retrospective review | Health care providers | Clinical research |
Evaluation of the sexual health in people living with hemophilia | Germini F, Chai-Adisaksopha C, Pete D, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker JS, Thabane L, Crowther MA, Skinner MW, Iorio A | 2021 | Haemophilia | View Evaluation of the sexual health in people living with hemophilia | Researchers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Chapter 4: Clinical transfusion procedures | Clarke G, Al-Riyami AZ, Roxby D | 2021 | Educational Modules on Clinical Use of Blood | View Chapter 4: Clinical transfusion procedures | Health care providers | Benchmarking and standard setting |
ResearchUnit: Platelet Transfusion in Children with Cancer | Barty R | 2021 | Blood.ca website | View ResearchUnit: Platelet Transfusion in Children with Cancer | Health care providers | Benchmarking and standard setting |
Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy | Balitsky AK, Liu Y, Van der Meer PF, Heddle NM, Arnold DM | 2021 | Transfusion | View Exploring the components of bleeding outcomes in transfusion trials for patients with hematologic malignancy | Researchers | Clinical research |
Irradiated, Washed and CMV Seronegative Blood Components | Prokopchuk-Gauk O, Solh Z | 2021 | Clinical Guide to Transfusion | View Irradiated, Washed and CMV Seronegative Blood Components | Health care providers | Benchmarking and standard setting |
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Saeed S, Drews SJ, Pambrun C, Yi Q-L, Osmond L, O'Brien SF | 2021 | Transfusion | View SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada | Researchers | Clinical research |
Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Verma AA, Pai M, Saha S, Bean S, Fralick M, Gibson JL, Greenberg RA, Kwan JL, Lapointe-Shaw L, Tang T, Morris AM, Razak F | 2021 | CMAJ | View Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Health care providers | Benchmarking and standard setting |
Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Ma Y, Hadjesfandiari N, Doschak M, Devine D, Tonelli M, Unsworth L | 2021 | Langmuir | View Peptide-Modified Surfaces for Binding Carbamylated Proteins from Plasma | Researchers | Basic research |
A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Jiang D, Lim W, Crowther M, Garcia D | 2021 | Blood Adv | View A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Researchers | Clinical research |
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial | Bégin P, Callum J, Heddle NM, Cook R, Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chassé M, Devine DV, Robitalle N, Bazin R, Shehata N, Finzi A, McGeer A, Scales DC, Schwartz L, Turgeon AF, Zarychanski R, Daneman N, Carl R, Amorim L, Gabe C, Ellis M, Sachais BS, Loftsgard KC, Jamula E, Carruthers J, Duncan J, Lucier K, Li N, Liu Y, Armali C, Kron A, Modi D, Auclair M-C, Cerro S, Avram M, Arnold DM | 2021 | Trials | View Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial | Researchers | Clinical research |
Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study | Alabdullatif M, Osman IE, Alrasheed M, Ramirez-Arcos S, Alyousef M, Althawadi S, Alhumiadan H | 2021 | Transfusion | View Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study | Researchers | New or improved product or process |
A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors | Drews SJ, Devine DV, McManus J, Mendoza E, Manguiat K, Wood H, Girardin R, Dupuis A, McDonough K, Drebot M | 2021 | Transfusion | View A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors | Researchers | Basic research |
Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference | Spinella PC, El Kassar N, Cap AP, Kindzelski AL, Almond CS, Barkun A, Gernsheimer TB, Goldstein JN, Holcomb JB, Iorio A, Jensen DM, Key NS, Levy JH, Mayer SA, Moore EE, Stanworth SJ, Lewis RJ, Steiner ME | 2021 | J Trauma Acute Care Surg | View Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference | Researchers | Benchmarking and standard setting |
ResearchUnit: Treating bleeding during cardiac surgery: Is prothrombin complex concentrate a substitute for plasma? | Kron A | 2021 | Blood.ca website | View ResearchUnit: Treating bleeding during cardiac surgery: Is prothrombin complex concentrate a substitute for plasma? | Health care providers | Clinical research |
The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP | 2021 | Cytotherapy | View The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation | Blood operators | New or improved product or process |
Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider | El-Khoury H, Saifi O, Haddad S, Chahrour M, Ghanem KM, Mubarak Y, Tamim H, Makki M, Zakka C, Chan AK, Mahfouz R, Tarek N, El-Solh H, Abboud MR, Saab R, Muwakkit SA | 2021 | Pediatr Blood Cancer | View Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider | Health care providers | Clinical research |
Discrete-Event Simulation to Model the Thrombolysis Process for Acute Ischemic Stroke Patients at Urban and Rural Hospitals | Bulmer T, Volders D, Blake J, Kamal N | 2021 | Front Neurol | View Discrete-Event Simulation to Model the Thrombolysis Process for Acute Ischemic Stroke Patients at Urban and Rural Hospitals | Researchers | New or improved product or process |